Clinical Trial Update: Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy [NA]

View source ↗

Summary

This completed clinical trial evaluates whether Ginger extract (Ginpax) can reduce nausea in cancer patients receiving highly emetogenic chemotherapy alongside …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Ginpax (Ginger (Zingiber officinale) extract)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Cancer, Nausea | NA | Status: COMPLETED